B. Tardy-Poncet

Université Claude Bernard Lyon 1 — France

Medicine · Health Sciences

20h-index1.1kcitations54works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Heparin-Induced Thrombocytopenia and Thrombosis(23), Venous Thromboembolism Diagnosis and Management(21), Intramuscular injections and effects(15), Blood Coagulation and Thrombosis Mechanisms(11), Platelet Disorders and Treatments(10)

Publications54 total

Obstetrical complications in hereditary fibrinogen disorders: the Fibrinogest study
Journal of Thrombosis and Haemostasis·2023· 21 citedOpen Access
Switch to pdVWF:pdFVIII concentrate for prophylaxis in a paediatric patient with Type 3 von Willebrand disease: a case report
Hematology·2023Open Access
Patient-Specific Modelling of Blood Coagulation
Bulletin of Mathematical Biology·2021· 22 citedOpen Access
Surgery with emicizumab prophylaxis for two pediatric patients with severe haemophilia A with inhibitors
2020Open Access
Comparative Analysis of a French Prospective Series of 144 Patients with Heparin-Induced Thrombocytopenia (FRIGTIH) and the Literature
Thrombosis and Haemostasis·2020· 44 cited
Clustering of Thrombin Generation Test Data Using a Reduced Mathematical Model of Blood Coagulation
Acta Biotheoretica·2019· 13 cited
Effect of heparin thromboprophylaxis on thrombin generation in multiple myeloma patients
British Journal of Haematology·2019· 4 citedOpen Access
Diagnosis of Heparin-Induced Thrombocytopenia: Development and Validation of a Predictive Clinical Score Based on Objective Features Identified by a Multivariate Analysis of a Multinational Prospective Study
SSRN Electronic Journal·2019Open Access
Evaluation and Calibration of In Silico Models of Thrombin Generation Using Experimental Data from Healthy and Haemophilic Subjects
Bulletin of Mathematical Biology·2018· 12 cited
Heparininduzierte Thrombozytopenie: Argatroban überzeugt
Journal Club AINS·2016
Anticoagulant properties of enoxaparin 400 IU/mL–40 % ethanol catheter lock solution
SpringerPlus·2015· 6 citedOpen Access
Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial
Critical Care·2015· 56 citedOpen Access
Chapitre 23 – Thrombopénies induites par les héparines
2015
Delayed-onset heparin-induced thrombocytopenia without thrombosis in a patient receiving postoperative thromboprophylaxis with rivaroxaban
Thrombosis and Haemostasis·2015· 24 cited
Potential roles of TFPI in both thrombotic and hemorrhagic diseases
HAL (Le Centre pour la Communication Scientifique Directe)·2012Open Access
TFPI resistance related to inherited or acquired protein S deficiency
Thrombosis Research·2012· 5 cited
Myélome multiple de novo : faut-il proposer une prophylaxie antithrombotique ?
La Revue de Médecine Interne·2012
Experts’ opinion or the serotonin release assay as a gold standard for the diagnosis of heparin‐induced thrombocytopenia (HIT)?
Journal of Thrombosis and Haemostasis·2011· 20 citedOpen Access
Difference in TFPI levels between haemophilia A and B patients
Haemophilia·2010· 7 cited
Thrombin generation and heparin‐induced thrombocytopenia
Journal of Thrombosis and Haemostasis·2009· 41 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Bernard Tardy(26), J. Reynaud(12), Patrick Mismetti(11), Michèle Piot(10), Hervé Decousus(9), D Guyotat(7), Thomas Lecompte(6), Ismaı̈l Elalamy(6), Yves Gruel(6), Brigitte Tardy(6), S Laporte‐Simitsidis(6), Yves Page(5), Emmanuel de Maistre(5), Martine Alhenc‐Gelas(4), Anne Bauters(4), A. Mulot(4), Aurélie Montmartin(4), C. Comtet(4), Fabrice Zéni(4), Alain Viallon(3)